We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Springer Vaccines for Pandemic Influenza: 333 (Current Topics in Microbiology and Immunology, 333)
Price data last checked 106 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans, resulting in numerous fatalities. The rapid expansion in their geographic distribution and the possibility that these viruses could acquire the ability to spread from person to person raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have little or no antigenic relationship to the highly pathogenic H5N1 strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop eff- tive vaccines for pandemic influenza viruses, and to overcome the limitations inh- ent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine prod- tion, which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations include the requirement that the current inac- vated influenza vaccines be administered using needles and syringes, requiring trained personnel, which could be a bottleneck when attempting to vaccinate large populations in mass campaigns. In addition, the current inactivated vaccines that are delivered by injection elicit limited protective immunity in the upper respiratory tract where the infection process is initiated.
Product Specifications
- Brand
- Springer
- Format
- hardcover
- ASIN
- 3540921648
- Domain
- Amazon UK
- Release Date
- 28 July 2009
- Listed Since
- 10 November 2008
Barcode
No barcode data available
Similar Products You Might Like
99% match
Vaccines for Pandemic Influenza: 333 (Current Topics in Microbiology and Immunology, 333)
Springer
£203.06
10 Mar 2026
94% match
Influenza Virology: Current Topics
Caister Academic Press Limited
£214.00
12 Jan 2026
93% match
Mucosal Vaccines: Modern Concepts, Strategies, and Challenges: 354 (Current Topics in Microbiology and Immunology, 354)
Springer
£107.43
09 Mar 2026
93% match
Influenza: Molecular Virology
Caister Academic Press Limited
£199.00
13 Jan 2026
92% match
Mucosal Vaccines: Modern Concepts, Strategies, and Challenges: 354 (Current Topics in Microbiology and Immunology, 354)
Springer
£101.00
09 Mar 2026
92% match
Plant-produced Microbial Vaccines: 332 (Current Topics in Microbiology and Immunology, 332)
Springer
£107.27
17 Feb 2026
92% match
Influenza
Springer
£75.60
07 Mar 2026
92% match
Vaccination Strategies Against Highly Variable Pathogens: 428 (Current Topics in Microbiology and Immunology, 428)
Springer
£95.11
07 Mar 2026
92% match
Vaccination Strategies Against Highly Variable Pathogens: 428 (Current Topics in Microbiology and Immunology, 428)
Springer
£95.72
07 Feb 2026
92% match
Influenza Pathogenesis and Control - Volume II: 386 (Current Topics in Microbiology and Immunology, 386)
Springer
£114.71
03 Mar 2026
92% match
Nanoparticles for Rational Vaccine Design: 433 (Current Topics in Microbiology and Immunology, 433)
Springer
£76.04
24 Feb 2026
92% match
Avian Virology: Current Research and Future Trends
Caister Academic Press Limited
£199.00
06 Jan 2026
92% match
Challenges and Opportunities for Respiratory Syncytial Virus Vaccines: 372 (Current Topics in Microbiology and Immunology, 372)
Springer
£112.76
07 Jan 2026
92% match
Human Challenge Studies for Vaccine Development: 445 (Current Topics in Microbiology and Immunology, 445)
£133.85
12 Jan 2026
92% match
Pulmonary Infection: 857 (Advances in Experimental Medicine and Biology, 857)
Springer
£72.63
06 Mar 2026
92% match
Modern Infectious Disease Epidemiology: Concepts, Methods, Mathematical Models, and Public Health (Statistics for Biology and Health)
Springer
£114.99
02 Mar 2026
92% match
Veterinary Vaccines: Current Innovations and Future Trends
Caister Academic Press Limited
£198.98
12 Jan 2026
92% match
Plotkin's Vaccines (Vaccines (Plotkin))
Elsevier
£204.71
16 Mar 2026
92% match
Convalescent Plasma and Other Antibody Therapies for Infectious Diseases: Lessons learned from COVID-19 and Future Prospects: 443 (Current Topics in Microbiology and Immunology, 443)
£147.93
06 Feb 2026
92% match
Springer Intradermal Immunization: 351 Microbiology Book
Springer
£107.43
07 Mar 2026
92% match
Springer Novel Strategies in Vaccine Design and Production 397
Springer
£109.03
10 Mar 2026
92% match
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
Springer
£119.08
18 Apr 2026
92% match
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
Springer
£126.23
08 Feb 2026
91% match
Antibodies in Viral Infection: 260 (Current Topics in Microbiology and Immunology, 260)
Springer
£144.44
10 Mar 2026